Medical Gas and Equipment Market

The medical gas and equipment market is projected to reach USD 30.05 billion by 2031 from USD 21.03 billion in 2025, at a CAGR of 6.2% during the forecast period.

The growth of the medical gas and equipment market can be mainly attributed to the fact that healthcare systems globally are unable to meet the demands for respiratory and critical care services due to a significant number of patients, including those with chronic diseases that continue to increase, such as COPD, asthma, cardiovascular disorders, and other conditions, including Coronavirus and cancer. Patients with chronic diseases, in any case, need long and effective therapy with medicinal gases and devices that can supply oxygen and nitrous oxide in a safe and efficient manner. This trend is also supported by the existence of a senior population, which generally requires more frequent and long-term medical interventions. In addition, the growth and renovation of healthcare establishments, especially in developing countries, and government investments in hospitals, surgical centers, and home care services are the main drivers of medical gas system installations and upgrades. Additionally, developments in technologies for smart gas delivery systems, automated monitoring, and portable devices not only make medical treatments more effective but also more accessible in home healthcare settings. In general, these elements are driving a steady rise in demand for medical gases and the devices used to administer them.

To know about the assumptions considered for the study download the pdf brochure

The prominent players in the medical gas and equipment market include-  Air Liquide (France), Linde PLC (Germany), Air Products and Chemicals, Inc. (US), Messer SE & Co. KGaA (Germany), Taiyo Nippon Sanso Corporation (Japan)

Major players in the medical gas and equipment market include Air Liquide, Linde plc, Air Products and Chemicals Inc., Messer SE & Co. KGaA, and Taiyo Nippon Sanso Corporation. These top multinational companies hold strong positions globally by virtue of their vast production capacities, innovative product ranges, and well-established distribution networks. These companies supply a wide variety of medical gases, including oxygen, nitrogen, nitrous oxide, and specialty gas mixtures, along with corresponding delivery systems and hospital, clinic, and home care-specific services. Regular reinvestment in advanced technologies for gas production, digital monitoring systems, and safety-compliant infrastructure makes the stability of their supply in both acute and long-term care settings a significant factor in their leadership. In addition, building a strong presence across North America, Europe, and the Asia Pacific region, and leveraging strategic partnerships, acquisitions, and long-term contracts with healthcare providers, have given these companies competitive advantages that have helped them secure a considerable share in the global medical gas and equipment market.

• In April 2025, Air Liquide introduced ECO ORIGIN as an environmentally friendly medical and industrial gas solution complementary to client needs. The offer covers essential gases like oxygen, nitrogen, argon, and carbon dioxide, made from pure renewable energy sources and accompanied by an ISO standardized carbon footprint from production to delivery. After the first launch devoted to healthcare customers and then promoted to various industries, ECO ORIGIN has been widely accepted in a very short time. This is evidenced by the signatures on agreements from more than 20 hospitals and clinics in six European countries, where the need for sustainable medical gas solutions is  ‍‌‍‍‌‍‌‍‍‌strongest.
• In June 2025, ESAB‍‌‍‍‌‍‌‍‍‌ Corporation (GCE) has improved its medical gas equipment portfolio by purchasing Delta P Gas Equipment, a company located in Italy, and by making a decision to buy Aktiv Technologies in India. The acquisitions allow ESAB to provide more complete medical central gas systems solutions, have a better global presence, and be more safety and regulatory compliance oriented in their gas control equipment ‍‌‍‍‌‍‌‍‍‌offering.
• In June 2024, Messer Americas successfully completed its purchase of the Federal Helium System from the U.S. Bureau of Land Management (BLM), marking the transition of this critical national resource from federal to private ownership. The Federal Helium System, comprising the Federal Helium Reserve, the Cliffside Field and wells, the 423-mile crude helium pipeline, and related operational assets, has historically played a central role in helium supply for sectors including healthcare (eg, MRI machines and breathing gas mixtures), research, aerospace, and manufacturing.

Air Liquide (France)

Air Liquide S.A. has been a renowned French multinational corporation worldwide for over a hundred years. The company, based in Paris, is a global leader in the production and distribution of industrial and medical gases, and it also provides related technologies and services. Air Liquide was founded in 1902 and today extends its business activities to more than 70 countries, reaching hundreds of thousands of customers, including healthcare providers and patients, all over the world. Medical gases and equipment in hospital and home healthcare are a main factor in the Air Liquide Medical Gases and Equipment Division. This division provides essential gases such as medical oxygen for respiratory and intensive care, therapeutic gas mixtures with nitrous oxide and oxygen for analgesia, and nitric oxide for critical care, thus ensuring the highest safety and quality standards through hospital distribution systems and on-site installations. Air Liquide Healthcare, the Company's specialized branch, provides home healthcare services and innovative gas delivery systems, and supports the treatment of chronic diseases outside hospital settings, thereby reaching millions of patients worldwide. Also, the company's large-scale production and distribution facilities, strong commitment to R&D for healthcare solutions, and long-term contracts with medical institutions have together placed Air Liquide in the foremost position of the medical gas and equipment market.

Linde PLC (Germany)

Linde PLC is a leading global industrial gas and engineering company that plays a major role in the US medical gas and equipment market. The company was formed in 2018 through the merger of Germany's Linde AG and the US-founded Praxair and is a leader in the supply of medical gases, such as oxygen for respiratory therapy, nitrogen for preservation, and helium for medical imaging, along with the delivery infrastructure and services to hospitals, clinics, laboratories, and nursing homes in the United States. Linde's healthcare portfolio is the perfect combination of high-quality gas production and a comprehensive distribution and support package, backed by one of the largest gas supply networks in the country. Its US operations are a dependable source of medical gas supply and related equipment, making it easier for healthcare providers to ensure the continuity of care while complying with strict safety and quality standards. In addition to hospital core supply, Linde also facilitates home care respiratory therapy through subsidiaries and network partners, thereby consolidating its position in the healthcare industry across different care settings.

MARKET RANKING

Air Liquide, Linde plc, Air Products and Chemicals Inc., Messer SE & Co. KGaA, and Taiyo Nippon Sanso Corporation are the major companies in the global medical gas and equipment market, a position that reflects their size, advanced technology, and global presence. These firms have a large market share in medical gas due to their extensive manufacturing capacity, reliable distribution, and established contracting networks with hospitals, healthcare systems, and home care providers. By virtue of their broad healthcare product portfolios, significant medical gas infrastructure investments, and strong presence in Europe, North America, and the Asia Pacific region, Air Liquide and Linde plc rank at the top. Air Products and Chemicals is well-positioned mainly because of its top-notch technologies, dependable bulk and packaged gas supply, and a particularly strong presence in the US market. Messer SE & Co. KGaA and Taiyo Nippon Sanso Corporation elevate the competition through their solid market leadership in Europe and Asia, respectively, supported by continuous growth, strategic alliances, and an emphasis on high-quality medical gas solutions.

Related Reports:

Medical Gas and Equipment Market by Type [Medical Gas (Oxygen, Nitrous Oxide), Medical Gas Equipment (Flowmeter, Others)], Application [Therapeutics, Diagnostics], End User (Hospital, Home Healthcare]-Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com